<?xml version="1.0" encoding="UTF-8"?>
<p id="Par55">Most studies aimed at preparing a universal M2e-based influenza vaccine have used the whole M2 ectodomain (a.a. 2–24). However, truncated forms of M2e (Table 
 <xref rid="Tab1" ref-type="table">1</xref>) can be used to induce an immune response to important areas of M2e, reduce the cost of vaccine production and allow the use of new vectors that have a small capacity. For example, there are a number of antibodies (14C2, 3F12, 8C6, 1B12, Z3G1) [
 <xref ref-type="bibr" rid="CR30">30</xref>, 
 <xref ref-type="bibr" rid="CR78">78</xref>, 
 <xref ref-type="bibr" rid="CR140">140</xref>] that recognize only a fraction of the total M2e, and that find wide application in practice. 
</p>
